Two Sigma Advisers’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-515
| Closed | -$19.5K | – | 2722 |
|
|
2023
Q1 | $19.5K | Sell |
515
-2,145
| -81% | -$81.1K | ﹤0.01% | 2520 |
|
|
2022
Q4 | $79.3K | Sell |
2,660
-2,375
| -47% | -$70.8K | ﹤0.01% | 2322 |
|
|
2022
Q3 | $168K | Sell |
5,035
-2,990
| -37% | -$99.8K | ﹤0.01% | 2236 |
|
|
2022
Q2 | $321K | Sell |
8,025
-2,425
| -23% | -$97K | ﹤0.01% | 2093 |
|
|
2022
Q1 | $550K | Sell |
10,450
-6,150
| -37% | -$324K | ﹤0.01% | 1936 |
|
|
2021
Q4 | $920K | Sell |
16,600
-1,790
| -10% | -$99.2K | ﹤0.01% | 1603 |
|
|
2021
Q3 | $1.42M | Buy |
18,390
+4,185
| +29% | +$324K | ﹤0.01% | 1435 |
|
|
2021
Q2 | $1.84M | Sell |
14,205
-1,165
| -8% | -$151K | ﹤0.01% | 1328 |
|
|
2021
Q1 | $2.53M | Buy |
15,370
+2,685
| +21% | +$442K | 0.01% | 1155 |
|
|
2020
Q4 | $2.97M | Buy |
+12,685
| New | +$2.97M | 0.01% | 1067 |
|
|
2020
Q3 | – | Sell |
-2,770
| Closed | -$109K | – | 2678 |
|
|
2020
Q2 | $109K | Buy |
2,770
+2,120
| +326% | +$83.4K | ﹤0.01% | 2346 |
|
|
2020
Q1 | $22K | Buy |
+650
| New | +$22K | ﹤0.01% | 2411 |
|